This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2i5j
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="2i5j" size="450" color="white" frame="true" align="right" spinBox="true" caption="2i5j, resolution 3.150Å" /> '''Crystal structure ...)
Next diff →
Revision as of 12:45, 8 November 2007
|
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with DHBNH, an RNASE H inhibitor
Overview
The rapid emergence of drug-resistant variants of human immunodeficiency, virus, type 1 (HIV-1), has limited the efficacy of anti-acquired immune, deficiency syndrome (AIDS) treatments, and new lead compounds that target, novel binding sites are needed. We have determined the 3.15 A resolution, crystal structure of HIV-1 reverse transcriptase (RT) complexed with, dihydroxy benzoyl naphthyl hydrazone (DHBNH), an HIV-1 RT RNase H (RNH), inhibitor (RNHI). DHBNH is effective against a variety of drug-resistant, HIV-1 RT mutants. While DHBNH has little effect on most aspects of, RT-catalyzed DNA synthesis, at relatively high concentrations it does, inhibit the initiation of RNA-primed DNA synthesis. Although primarily an, RNHI, DHBNH binds >50 A away from the RNH active site, at a novel site, near both the polymerase active site and the non-nucleoside RT inhibitor, (NNRTI) binding pocket. When DHBNH binds, both Tyr181 and Tyr188 remain in, the conformations seen in unliganded HIV-1 RT. DHBNH interacts with, conserved residues (Asp186, Trp229) and has substantial interactions with, the backbones of several less well-conserved residues. On the basis of, this structure, we designed substituted DHBNH derivatives that interact, with the NNRTI-binding pocket. These compounds inhibit both the polymerase, and RNH activities of RT.
About this Structure
2I5J is a Protein complex structure of sequences from Human immunodeficiency virus 1 with GLC, SUC, MG and K05 as ligands. Active as RNA-directed DNA polymerase, with EC number 2.7.7.49 Full crystallographic information is available from OCA.
Reference
HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site., Himmel DM, Sarafianos SG, Dharmasena S, Hossain MM, McCoy-Simandle K, Ilina T, Clark AD Jr, Knight JL, Julias JG, Clark PK, Krogh-Jespersen K, Levy RM, Hughes SH, Parniak MA, Arnold E, ACS Chem Biol. 2006 Dec 20;1(11):702-12. PMID:17184135
Page seeded by OCA on Thu Nov 8 14:51:30 2007
Categories: Human immunodeficiency virus 1 | Protein complex | RNA-directed DNA polymerase | Arnold, E. | Himmel, D.M. | Knight, J.L. | Levy, R.M. | Sarafianos, S.G. | GLC | K05 | MG | SUC | Aids | Crystal structure | Drug resistance | Hiv | Protein-inhibitor complex | Reverse transcriptase | Rnase h inhibitor | Rnhi | Rt | Structure-based drug design
